April 29, 2020 / 12:38 AM / a month ago

BRIEF-Erytech Granted U.S. FDA Fast Track Designation For Eryaspase In Second-Line Pancreatic Cancer

April 28 (Reuters) - Erytech Pharma SA:

* ERYTECH GRANTED U.S. FDA FAST TRACK DESIGNATION FOR ERYASPASE IN SECOND-LINE PANCREATIC CANCER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below